| Financial Year |
March 31 2023 |
| Monetary Funds |
937,529,035.38 |
| Held-for-trading Financial Assets |
456,423,994.05 |
| Notes Receivable |
329,084,318.28 |
| Accounts Receivable |
495,689,074.95 |
| Advances to Suppliers |
116,886,882.35 |
| Other Receivables |
7,585,743.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
474,104,924.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
40,256,834.78 |
| Total Current Assets |
2,940,351,795.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,454,835.63 |
| Investment Properties |
-- |
| Fixed Assetes |
1,319,509,609.27 |
| Under-construction Projects |
223,542,201.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
152,293,094.86 |
| R&D expenses |
-- |
| Goodwill |
122,283,779.67 |
| Long-Term Deferred and Prepaid Expenses |
8,130,887.81 |
| Deferred Income Tax Assets |
43,880,274.16 |
| Other Non-Current Assets |
190,987,986.82 |
| Sub-Total of Non-Current Assets |
2,075,578,663.30 |
| Total Assets |
5,015,930,458.33 |
| Short-Term Loans |
18,794,166.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
251,387,870.24 |
| Accounts Payable |
267,300,670.35 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
30,450,104.27 |
| Taxes Payable |
43,273,861.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
28,071,215.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,018,338.63 |
| Other Current Liabilities |
70,085,689.17 |
| Sub-Total of Current Liabilities |
729,059,939.89 |
| Long-term Loans |
71,502,445.98 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
10,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
68,482,945.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
303,748,863.69 |
| Total Liabilities |
1,032,808,803.58 |
| Paid-In Capital(Or Share Stock) |
516,014,473.00 |
| Capital Surplus |
1,222,380,567.58 |
| Surplus Reserve |
182,492,949.90 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,577,019,030.59 |
| Minority Stockholder's Interest |
485,214,633.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,497,907,021.07 |
| Owner's Equity（Stockholder's Equity） |
3,983,121,654.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,015,930,458.33 |
